Bionomics Ltd (External organisation)

Description

Novel chromenone potassium channel blockers and uses thereof

Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

WO2008040058A1 - WIPO (PCT)
Application PCT/AU2007/001476 events
2006-10-04 Priority to US84925606P
2006-10-04 Priority to US60/849,256
2007-10-04 Application filed by Bionomics Limited
2008-04-10 Publication of WO2008040058A1

Related patent documents
US2987256 US20090063541 US20090298931 AU2007304881 NZ575686

Period	2008
Held at	Bionomics Ltd, Australia, South Australia
Degree of Recognition	International